Entact Bio

Entact Bio is at the forefront of biotechnology research, dedicated to creating innovative medicines by enhancing protein function. Located in Watertown, Massachusetts, Entact Bio focuses on developing precision medicines designed to improve the activity of beneficial proteins, expanding therapeutic possibilities and redefining treatment paradigms.

With its proprietary Encompass™ platform, Entact Bio is pioneering enhancement-targeting chimeric (ENTAC™) medicines. This groundbreaking approach leverages the natural capabilities of deubiquitylases (DUBs) to regulate and enhance protein function. Entact Bio's primary address is in Watertown, Massachusetts 02472, US, positioning the company within a vibrant hub of biotechnology innovation.

Entact Bio is committed to addressing diseases underserved by current therapeutic options, offering new hope and improved outcomes for patients. The company’s work promises to expand the scope of treatable conditions through its unique focus on protein enhancement. We invite the management team at Entact Bio to create a customized and exclusive company showcase and product listing on our platform, further highlighting their contributions to the field.